Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorPsychiatric University Hospital, Zurich

About this trial

The main aim of this project is to improve waiting periods for specialised psychotherapy. We will apply a brief, smartphone-based self-efficacy training to patients with psychiatric disorders waiting for specialised psychotherapy. Additionally, we will use Ecological Momentary Assessment (EMA) to assess mood, social contacts, and other parameters daily. We will investigate whether the training can improve self-efficacy and related constructs and if it can help reduce stress and waitlist drop-outs during waiting periods. Additionally, we will investigate if the self-efficacy training has a positive effect on motivation and therapeutical relationship regarding the subsequent therapy.

After a screening for eligibility, participants will be randomly assigned to intervention and control group. At baseline, participants attend a laboratory session where they are assessed for current psychiatric disorders and further relevant psychological variables. They will then either participate in the digital self-efficacy training combined with EMA (intervention group) or in EMA only (control group). Both will be conducted via a smartphone app. Subsequently, participants will be asked to fill in post questionnaires at three different time points: after having finished app usage, one month later, and after the beginning of the subsequent psychotherapy.

Eligibility criteria

Qualifiers

psychiatric disorder

age 18-65

waiting for psychiatric assessment/treatment (being on waitlist)

sufficient knowledge of the German language

Disqualifiers

current intense psychotherapy

acute suicidality

acute psychotic symptoms

substance addiction

Trial design

Treatments tested in this trial

  • Digital self-efficacy training
  • Ecological Momentary Assessment

Treatment groups

94 Participants
are divided into 2 treatment groups